Grantham, Mayo, Van Otterloo & Co (GMO)
XP icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s XP XP Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio XP Stock Details XP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-91,200
Closed -$1.64M – 619
2024
Q3 		$1.64M Buy
+91,200
New +$1.66M 0.01% 390
2020
Q1 		– Sell
-139,500
Closed -$5.37M – 835
2019
Q4 		$5.37M Buy
+139,500
New +$5.24M 0.04% 280

Other funds holding XP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Squadra Investments Rio De Janeiro, Brazil $894M AUM 33.04% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s XP Position: Q4 2024 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of XP (XP) in Q4 2024, closing a stake of 91,200 shares — an estimated $1.64M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in XP in Q4 2019 and held it in 2 quarters. The position peaked at $5.37M in Q4 2019. 294 funds tracked by Wall St. Rank hold XP as of Q4 2024.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining XP position as of Q4 2024 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 91,200 XP shares in Q4 2024, an estimated $1.64M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in XP in Q4 2019 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s XP position peaked at $5.37M in Q4 2019.
  • 294 funds tracked by Wall St. Rank held XP as of Q4 2024.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2024, filed 13 Feb 2025.